If you go back and look at all the stock pictures, Bellamys, Aptamil & A2 have had a huge 6 months. There is no way BAL has done less than $260mill, and highly likely $270mill+
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status